The rise of women’s health It’s been a Barbie world this summer with crowds of pink-clad moviegoers flooding the cinemas. Simultaneously, we’ve been witnessing a […] November 15, 2023 · V-Bio Ventures
QbD Chair for Precision Oncology Research in Glioblastoma extended for three years The QbD Chair supports the research of Professor Frederik De Smet on glioblastoma, an aggressive form of brain cancer. Behind […] January 22, 2024 · Press Release
Pioneering Belgian project ATHENA paves the way for Real-World Data reuse in research and personalized care Leuven, Belgium, 21 November 2023 – ATHENA, a VLAIO-funded multi-stakeholder project, clears the path for increased reuse of Real-World Data […] November 21, 2023 · Press Release
Byteflies: virtual care solutions for all Byteflies is on a mission to make virtual care available to all. The Belgian company has developed a platform for […] May 24, 2023 · MEDVIA
Colorectal cancer discovery raises hope for microbiome treatment A new mechanism causing colorectal cancer has been discovered by researchers from VIB and Ghent University. A specific protein was […] July 7, 2020 · BioVox
Newton Biocapital I invests in J-Pharma Co., Ltd. in Japan focusing on drug development targeting L-type Amino Acid Transporter 1 (LAT1) for cancer and autoimmune diseases Brussels, Belgium / Tokyo, Japan – 27 August 2020 – Newton Biocapital I (“Newton”), an investment company in life sciences, […] August 27, 2020 · Press Release
Montis Biosciences appoints Karen Zinkewich-Péotti as Chief Executive Officer Leuven, Belgium, 29 September 2020 – Montis Biosciences, a discovery stage biotech company focused on novel immuno-oncology therapeutics targeting the […] September 29, 2020 · Press Release
Get to know Lewis Cantley: winner of the 2020 Dr. Paul Janssen Award Every year, the Dr. Paul Janssen Award for Biomedical Research is granted to a scientist who embodies the eponymous man’s […] September 30, 2020 · Janssen Pharmaceutica
Vascular dysfunction meets immune suppression Tumors create complex microenvironments where they suppress the normal functioning of the immune system. Blood vessels and macrophages are an […] November 4, 2020 · BioVox
Newton Biocapital I invests in Perseus Proteomics Inc. in Japan to develop therapeutic antibodies for the treatment of blood cancers Brussels, Belgium / Tokyo, Japan – 1 December 2020 – Newton Biocapital I (“Newton”), a life sciences investment fund active in Europe […] December 1, 2020 · Press Release
eTheRNA and China Grand Pharma enter a strategic collaboration in the Greater China Region focussed on eTheRNA’s proprietary mRNA development products and manufacturing capabilities Niel, Belgium, 1 December 2020 – eTheRNA immunotherapies NV (“eTheRNA”) announced it has entered into a strategic cooperation and product […] December 2, 2020 · Press Release
Decades-old discoveries cause paradigm shifts in modern medicine Complete paradigm shifts in medicine are rare, but there have nevertheless been several major examples in the past hundred years. […] December 16, 2020 · V-Bio Ventures
Onco-immunology Company Pan Cancer T Launched as Spin-off from Erasmus Medical Center – Dutch biotech company developing first-in-class T-cell Receptor (TCR) T-cell therapies – Seed investment by Swanbridge Capital and Van Herk […] February 8, 2021 · Press Release
Newton Biocapital invests in Flemish start-up DeuterOncology Brussels, Belgium, 24 February 2021 – Newton Biocapital I (“Newton Biocapital”), a life sciences investment fund active in Europe and […] February 24, 2021 · Press Release
Saving man’s best friend: Volition blood test allows cheap and easy cancer screenings for dogs A Belgian invention is revolutionizing cancer diagnostics for dogs by making it possible to screen for two common canine cancers […] March 10, 2021 · BioVox